Salt-Responsive Metabolite, β-Hydroxybutyrate, Attenuates Hypertension

Abstract

Dietary salt reduction and exercise are lifestyle modifications for salt‐sensitive hypertensives. While exercise has prominent metabolic effects, salt has an adverse effect on metabolic syndrome, of which hypertension is a hallmark. We hypothesized that dietary salt impacts metabolism in a salt‐sensitive model of hypertension. An untargeted metabolomics approach demonstrates lower circulating levels of the ketone body, beta‐hydroxybutyrate (βOHB), in high salt‐fed hypertensive rats. Despite the high salt intake, specific rescue of βOHB levels by nutritional supplementation of its precursor, 1,3‐butanediol, attenuates hypertension and protects kidney function. This beneficial effect of βOHB was likely independent of gut‐microbiotal and Th17‐mediated effects of salt and instead facilitated by βOHB inhibiting the renal Nlrp3 inflammasome. The juxtaposed effects of dietary salt and exercise on salt‐sensitive hypertension, which decrease and increase βOHB respectively, indicate that nutritional supplementation of a precursor of βOHB provides a similar benefit to salt‐sensitive hypertension as exercise. Support or Funding Information Funding from this work to BJ from the NHLBI (NIH) (HL143082) is gratefully acknowledged. Declaration of interests: Bina Joe and Saroj Chakraborty have an interest in U.S. Patent Application Serial No.: 62/665,690 filed on May 2, 2018 in this paper regarding nutritional intervention for salt‐sensitive hypertension for 1,3‐butanediol. This abstract is from the Experimental Biology 2019 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

“…This suggests that the mechanism of benefit is likely to be independent of glucose levels and may possibly stem from a reduction in intraglomerular pressure, [11][12][13] with other possible mechanisms presently being studied. [14][15][16][17] Our trial population was also at high risk for cardiovascular outcomes, with cardiovascular death, myocardial infarction, stroke, or hospitalization for heart failure occurring in 13.8% of the population over a median of 2.62 years of follow-up. The significantly lower rates of cardiovascular outcomes, including the composite of cardiovascular death, myocardial infarction, or stroke, in the canagliflozin group in our trial are consistent with those observed with canagliflozin in the CANVAS (Canagliflozin Cardiovascular Assessment Study) Program, 5 despite the smaller differences in glycemic control.…”

Modulation of Cellular Biochemistry, Epigenetics and Metabolomics by Ketone Bodies. Implications of the Ketogenic Diet in the Physiology of the Organism and Pathological States

“…Dietary administration of the BHB precursor 1,3-butanediol to rats on a high-salt diet reverted blood pressure to values observed in a low salt diet control group. Moreover, administration of 1,3-butanediol reduced the activity of the Nlrp3 inflammasome, a major inductor of the expression of inflammatory factors, such as caspase-1, IL-1β and IL-18 [58].…”

“…Experiments performed on rats showed that blood pressure raises with salt content in the diet and is reduced under mild ketosis [57,58]. Dietary administration of the BHB precursor 1,3-butanediol to rats on a high-salt diet reverted blood pressure to values observed in a low salt diet control group.…”

Short-chain fatty acid, acylation and cardiovascular diseases

“…Nutritional or pharmacological activation of GPR109A ameliorates inflammation [144]. In salt-sensitive hypertension, nutritional supplementation of β-hydroxybutyrate precursor, 1,3-butanediol, increases the level of β-hydroxybutyrate and attenuates hypertension through repressing the formation of renal NLRP3 inflammasome [145,146]. Moreover, β-hydroxybutyrate receptor (GPR109A) mediates a significant anti-inflammatory role in various diseases, including atherosclerosis [147].…”